METHOD FOR DECREASING BETA-AMYLOID PROTEIN
PROBLEM TO BE SOLVED: To provide a diagnostic agent and a medicine for decreasing the production of an amyloid β protein, thereby preventing or suppressing conditions liable to develop AD. SOLUTION: A blood cholesterol level is correlated with production of Aβ, and is a predictor of a population at...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YANKNER BRUCE A NADEAU PHILIP |
| description | PROBLEM TO BE SOLVED: To provide a diagnostic agent and a medicine for decreasing the production of an amyloid β protein, thereby preventing or suppressing conditions liable to develop AD. SOLUTION: A blood cholesterol level is correlated with production of Aβ, and is a predictor of a population at risk of developing AD. The method for lowering a blood cholesterol level can be used to decrease the production of Aβ, and thereby decrease the risk of developing AD. The method and compositions can also be used for treating an individual diagnosed with AD. The method includes administration of compounds which increase uptake of cholesterol by the liver (such as an HMG CoA reductase inhibitor), administration of compositions which block endogenous cholesterol production (such as an HMG CoA reductase inhibitor), administration of compositions which prevent uptake of dietary cholesterol, and administration of combinations of any of these which are effective to lower a blood cholesterol level. COPYRIGHT: (C)2010,JPO&INPIT |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2010047616A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2010047616A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2010047616A3</originalsourceid><addsrcrecordid>eNrjZNDydQ3x8HdRcPMPUnBxdQ5ydQz29HNXcHINcdR19I308fd0UQgI8g9x9fTjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBoYGBibmZoZmjsZEKQIAiWsk8Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR DECREASING BETA-AMYLOID PROTEIN</title><source>esp@cenet</source><creator>YANKNER BRUCE A ; NADEAU PHILIP</creator><creatorcontrib>YANKNER BRUCE A ; NADEAU PHILIP</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a diagnostic agent and a medicine for decreasing the production of an amyloid β protein, thereby preventing or suppressing conditions liable to develop AD. SOLUTION: A blood cholesterol level is correlated with production of Aβ, and is a predictor of a population at risk of developing AD. The method for lowering a blood cholesterol level can be used to decrease the production of Aβ, and thereby decrease the risk of developing AD. The method and compositions can also be used for treating an individual diagnosed with AD. The method includes administration of compounds which increase uptake of cholesterol by the liver (such as an HMG CoA reductase inhibitor), administration of compositions which block endogenous cholesterol production (such as an HMG CoA reductase inhibitor), administration of compositions which prevent uptake of dietary cholesterol, and administration of combinations of any of these which are effective to lower a blood cholesterol level. COPYRIGHT: (C)2010,JPO&INPIT</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100304&DB=EPODOC&CC=JP&NR=2010047616A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100304&DB=EPODOC&CC=JP&NR=2010047616A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YANKNER BRUCE A</creatorcontrib><creatorcontrib>NADEAU PHILIP</creatorcontrib><title>METHOD FOR DECREASING BETA-AMYLOID PROTEIN</title><description>PROBLEM TO BE SOLVED: To provide a diagnostic agent and a medicine for decreasing the production of an amyloid β protein, thereby preventing or suppressing conditions liable to develop AD. SOLUTION: A blood cholesterol level is correlated with production of Aβ, and is a predictor of a population at risk of developing AD. The method for lowering a blood cholesterol level can be used to decrease the production of Aβ, and thereby decrease the risk of developing AD. The method and compositions can also be used for treating an individual diagnosed with AD. The method includes administration of compounds which increase uptake of cholesterol by the liver (such as an HMG CoA reductase inhibitor), administration of compositions which block endogenous cholesterol production (such as an HMG CoA reductase inhibitor), administration of compositions which prevent uptake of dietary cholesterol, and administration of combinations of any of these which are effective to lower a blood cholesterol level. COPYRIGHT: (C)2010,JPO&INPIT</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDydQ3x8HdRcPMPUnBxdQ5ydQz29HNXcHINcdR19I308fd0UQgI8g9x9fTjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBoYGBibmZoZmjsZEKQIAiWsk8Q</recordid><startdate>20100304</startdate><enddate>20100304</enddate><creator>YANKNER BRUCE A</creator><creator>NADEAU PHILIP</creator><scope>EVB</scope></search><sort><creationdate>20100304</creationdate><title>METHOD FOR DECREASING BETA-AMYLOID PROTEIN</title><author>YANKNER BRUCE A ; NADEAU PHILIP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2010047616A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>YANKNER BRUCE A</creatorcontrib><creatorcontrib>NADEAU PHILIP</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YANKNER BRUCE A</au><au>NADEAU PHILIP</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR DECREASING BETA-AMYLOID PROTEIN</title><date>2010-03-04</date><risdate>2010</risdate><abstract>PROBLEM TO BE SOLVED: To provide a diagnostic agent and a medicine for decreasing the production of an amyloid β protein, thereby preventing or suppressing conditions liable to develop AD. SOLUTION: A blood cholesterol level is correlated with production of Aβ, and is a predictor of a population at risk of developing AD. The method for lowering a blood cholesterol level can be used to decrease the production of Aβ, and thereby decrease the risk of developing AD. The method and compositions can also be used for treating an individual diagnosed with AD. The method includes administration of compounds which increase uptake of cholesterol by the liver (such as an HMG CoA reductase inhibitor), administration of compositions which block endogenous cholesterol production (such as an HMG CoA reductase inhibitor), administration of compositions which prevent uptake of dietary cholesterol, and administration of combinations of any of these which are effective to lower a blood cholesterol level. COPYRIGHT: (C)2010,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2010047616A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
| title | METHOD FOR DECREASING BETA-AMYLOID PROTEIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A28%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YANKNER%20BRUCE%20A&rft.date=2010-03-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2010047616A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |